Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease
figureposted on 2021-03-04, 17:00 authored by Adis journals on behalf of, Laurent Peyrin-Biroulet, Edouard Louis, Edward V. Loftus, Jr, Ana Lacerda, Qian Zhou, Yuri Sanchez Gonzalez, Subrata Ghosh
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.